4-(3-(4-bromophenyl)ureido)benzenesulfonamide

ID: ALA1643291

Chembl Id: CHEMBL1643291

PubChem CID: 27869982

Max Phase: Preclinical

Molecular Formula: C13H12BrN3O3S

Molecular Weight: 370.23

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Synonyms: 4-({[(4'-Bromophenyl)Amino]Carbonyl}Amino)Benzenesulfonamide | CHEMBL1643291|4-({[(4'-Bromophenyl)Amino]Carbonyl}Amino)Benzenesulfonamide|SCHEMBL671553|DXQKMYKLTXOZRT-UHFFFAOYSA-N|BDBM50334355|4-(3-(4-bromophenyl)ureido)benzenesulfonamide|4-({[(4''-Bromophenyl)amino]carbonyl}amino)benzenesulfonamide

Canonical SMILES:  NS(=O)(=O)c1ccc(NC(=O)Nc2ccc(Br)cc2)cc1

Standard InChI:  InChI=1S/C13H12BrN3O3S/c14-9-1-3-10(4-2-9)16-13(18)17-11-5-7-12(8-6-11)21(15,19)20/h1-8H,(H2,15,19,20)(H2,16,17,18)

Standard InChI Key:  DXQKMYKLTXOZRT-UHFFFAOYSA-N

Alternative Forms

Associated Targets(Human)

CA2 Tclin Carbonic anhydrase II (17698 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CA1 Tclin Carbonic anhydrase I (13240 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CA9 Tclin Carbonic anhydrase IX (8255 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CA12 Tclin Carbonic anhydrase XII (6231 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

mtcA1 Uncharacterized protein Rv1284/MT1322 (182 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PROBABLE TRANSMEMBRANE CARBONIC ANHYDRASE (CARBONATE DEHYDRATASE) (CARBONIC DEHYDRATASE) (107 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCE103 Carbonic anhydrase (137 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 370.23Molecular Weight (Monoisotopic): 368.9783AlogP: 2.74#Rotatable Bonds: 3
Polar Surface Area: 101.29Molecular Species: NEUTRALHBA: 3HBD: 3
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: 10.19CX Basic pKa: CX LogP: 2.49CX LogD: 2.49
Aromatic Rings: 2Heavy Atoms: 21QED Weighted: 0.77Np Likeness Score: -1.58

References

1. Pacchiano F, Carta F, Vullo D, Scozzafava A, Supuran CT..  (2011)  Inhibition of β-carbonic anhydrases with ureido-substituted benzenesulfonamides.,  21  (1): [PMID:21145236] [10.1016/j.bmcl.2010.11.064]
2. Pacchiano F, Carta F, McDonald PC, Lou Y, Vullo D, Scozzafava A, Dedhar S, Supuran CT..  (2011)  Ureido-substituted benzenesulfonamides potently inhibit carbonic anhydrase IX and show antimetastatic activity in a model of breast cancer metastasis.,  54  (6): [PMID:21361354] [10.1021/jm101541x]
3. Vullo D, Leewattanapasuk W, Mühlschlegel FA, Mastrolorenzo A, Capasso C, Supuran CT..  (2013)  Carbonic anhydrase inhibitors: inhibition of the β-class enzyme from the pathogenic yeast Candida glabrata with sulfonamides, sulfamates and sulfamides.,  23  (9): [PMID:23511020] [10.1016/j.bmcl.2013.02.092]

Source